Region Vaestmanland

The department is advancing pain‑control methods by comparing regional techniques, with a focus on improving postoperative recovery after major abdominal surgery. Researchers evaluate whether spinal morphine can match the benefits of epidural analgesia and assess patient‑reported quality of recovery.

• Spinal morphine versus epidural analgesia in colorectal surgery
• Quality of recovery assessment after anesthesia
• Optimization of peri‑operative analgesic protocols

These efforts are coordinated at Region Vaestmanland’s Infektionsmottagningen, contributing to safer and more comfortable surgical experiences for patients.

A broad portfolio of studies targets resistant bacterial pathogens, aiming to identify safer oral regimens and novel biologics. Trials investigate treatment of ESBL‑producing urinary tract infections, prevention of recurrent Clostridioides difficile infection, and optimal therapy for Staphylococcus aureus bacteraemia.

• Alternative antibiotics for multidrug‑resistant UTIs
• Monoclonal antibody to prevent C. difficile recurrence
• Comparative treatment of penicillin‑susceptible S. aureus bacteraemia
• Therapeutic drug monitoring of continuous cloxacillin infusion

The site’s infectious‑disease expertise supports the development of more effective and less toxic antimicrobial strategies.

Clinical research in this area concentrates on reducing major cardiac events and improving heart‑failure outcomes. Studies test self‑administered rescue medication for suspected acute myocardial infarction, evaluate novel LDL‑C‑lowering agents for patients with high cholesterol, and assess the impact of mineralocorticoid antagonists in heart failure with preserved ejection fraction.

• Self‑administered therapy for suspected acute myocardial infarction
• LDL‑C lowering with innovative agents in inherited hypercholesterolemia
• Reducing MACE in established atherosclerotic disease
• Spironolactone initiation in heart failure with preserved ejection fraction

These cardiovascular investigations are led by investigators at Vasteras, enhancing preventive and therapeutic options for patients at risk.

The site explores immune modulation across cancer and autoimmunity, seeking to refine treatment duration and improve disease control. Trials evaluate shorter adjuvant immunotherapy for high‑risk melanoma, test a new antibody for systemic lupus erythematosus, and assess the combined impact of national HPV vaccination and screening programs.

• Immunotherapy duration for high‑risk cutaneous melanoma
• Targeted therapy for systemic lupus erythematosus
• HPV vaccination and screening to reduce cervical disease
• Immune checkpoint modulation in autoimmune conditions

By integrating immunology with clinical practice, Region Vaestmanland contributes to more precise and patient‑friendly immune therapies.

Oncology research focuses on adjuvant strategies and molecularly guided treatments for several solid tumours. Projects examine the role of low‑dose aspirin in patients with PIK3CA‑mutated colorectal cancer, compare chemotherapy regimens for non‑metastatic testicular cancer, and test the efficacy of shortened immunotherapy courses in cutaneous malignant melanoma.

• Aspirin therapy in PIK3CA‑mutated colorectal cancer
• Adjuvant chemotherapy strategies for testicular cancer
• Stage‑specific treatment trials in cutaneous malignant melanoma
• Outcomes of resective colorectal surgery

These cancer trials, coordinated through Västmanlands sjukhus Västerås, aim to personalize care and lower relapse rates.

Neurological studies target rapid intervention and recovery after acute events and nerve injury. Research includes early administration of a kinase inhibitor for acute ischemic stroke to improve functional outcomes, and evaluation of oral corticosteroids for children with facial nerve palsy.

• Early imatinib administration in acute ischemic stroke
• Corticosteroid treatment for acute facial nerve palsy in children
• Neuro‑protective strategies in stroke recovery
• Functional outcome assessment after nerve injury

The investigations conducted at the Infektionsmottagningen unit strive to enhance neurological recovery and quality of life for affected patients.